BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36695557)

  • 21. Determination of Autoantibody Isotypes Increases the Sensitivity of Serodiagnostics in Rheumatoid Arthritis.
    Sieghart D; Platzer A; Studenic P; Alasti F; Grundhuber M; Swiniarski S; Horn T; Haslacher H; Blüml S; Smolen J; Steiner G
    Front Immunol; 2018; 9():876. PubMed ID: 29740454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-Citrullinated Protein Antibody Specificities, Rheumatoid Factor Isotypes, and Incident Cardiovascular Events in Patients With Rheumatoid Arthritis.
    Westerlind H; Rönnelid J; Hansson M; Alfredsson L; Mathsson-Alm L; Serre G; Cornillet M; Holmdahl R; Jakobsson PJ; Skriner K; Klareskog L; Saevarsdottir S; Askling J
    Arthritis Rheumatol; 2020 Oct; 72(10):1658-1667. PubMed ID: 32475073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti -citrullinated peptide antibodies profiling in established rheumatoid arthritis.
    Manca ML; Alunno A; D'Amato C; Bistoni O; Puxeddu I; Gerli R; Migliorini P; Pratesi F
    Joint Bone Spine; 2018 Jul; 85(4):441-445. PubMed ID: 28826660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Association of markers of rheumatoid arthritis in lupus. Is it a rhupus?].
    Bouchedoub Y; Djenouhat K; Rachedi N; Babasaci R; Ould Ali L; Salah K; Kherrache R; Kherbeche M; Khlifati A; Guernou FZ; Benzitouni A; Semmana M; Meghlaoui A
    Ann Biol Clin (Paris); 2020 Apr; 78(2):201-205. PubMed ID: 32319950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A case of anti-cyclic citrullinated peptides antibody positive rheumatoid meningitis without arthritis at the onset of neurological symptoms].
    Abe T; Mishima K; Uchino A; Sasaki A; Tanahashi N; Takao M
    Rinsho Shinkeigaku; 2016 Sep; 56(9):627-32. PubMed ID: 27580766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic utility of, and influence of tobacco usage and genetic predisposition on, immunoglobulin A, rheumatoid factor and anti-citrullinated peptide auto-antibodies in South African rheumatoid arthritis patients.
    Meyer P; Ally M; Hodkinson B; Anderson R; Tikly M
    Afr Health Sci; 2018 Jun; 18(2):295-303. PubMed ID: 30602956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rheumatoid meningitis: a rare cause of unilateral pachymeningitis.
    Grose D; Linger M; Tinni S; Sahathevan R
    BMJ Case Rep; 2019 Apr; 12(4):. PubMed ID: 30948395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum rheumatoid factor IgA, anti-citrullinated peptide antibodies with secretory components, and anti-carbamylated protein antibodies associate with interstitial lung disease in rheumatoid arthritis.
    Oka S; Higuchi T; Furukawa H; Shimada K; Okamoto A; Hashimoto A; Komiya A; Saisho K; Yoshikawa N; Katayama M; Matsui T; Fukui N; Migita K; Tohma S
    BMC Musculoskelet Disord; 2022 Jan; 23(1):46. PubMed ID: 35027028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibodies against citrullinated peptides are associated with clinical and radiological outcomes in patients with early rheumatoid arthritis: a prospective longitudinal inception cohort study.
    Boman A; Brink M; Lundquist A; Hansson M; Mathsson-Alm L; Rönnelid J; Berglin E; Holmdahl R; Skriner K; Serre G; Klareskog L; Rantapää-Dahlqvist S
    RMD Open; 2019; 5(2):e000946. PubMed ID: 31565241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Presence of autoantibodies in "seronegative" rheumatoid arthritis associates with classical risk factors and high disease activity.
    Reed E; Hedström AK; Hansson M; Mathsson-Alm L; Brynedal B; Saevarsdottir S; Cornillet M; Jakobsson PJ; Holmdahl R; Skriner K; Serre G; Alfredsson L; Rönnelid J; Lundberg K
    Arthritis Res Ther; 2020 Jul; 22(1):170. PubMed ID: 32678001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum IgG ACPA-IgM RF immune complexes were detected in rheumatoid arthritis patients positive for IgM ACPA.
    Haraguchi A; Yamada H; Kondo M; Okazaki K; Fukushi JI; Oyamada A; Yoshikai Y; Nakashima Y
    Clin Exp Rheumatol; 2018; 36(4):612-618. PubMed ID: 29465353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinctive Clinical Characteristics and Outcome of ILD-Onset Rheumatoid Arthritis and ACPA-Positive ILD: a Longitudinal Cohort of 282 Cases.
    Chen RX; Zhao LD; Xiao XY; Song L; Du HY; Xu ZJ; Feng RE; Yang HX; Fei YY; Zhang W; Zhang FC; Chen H; Zhang X
    Clin Rev Allergy Immunol; 2021 Feb; 60(1):46-54. PubMed ID: 33170478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence, sensitivity and specificity of antibodies against carbamylated proteins in a monocentric cohort of patients with rheumatoid arthritis and other autoimmune rheumatic diseases.
    Pecani A; Alessandri C; Spinelli FR; Priori R; Riccieri V; Di Franco M; Ceccarelli F; Colasanti T; Pendolino M; Mancini R; Truglia S; Barbati C; Vomero M; Sabatinelli D; Morello F; Valesini G; Conti F
    Arthritis Res Ther; 2016 Nov; 18(1):276. PubMed ID: 27887639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Performance characteristics of rheumatoid factor and anti-cyclic citrullinated peptide antibody assays may impact ACR/EULAR classification of rheumatoid arthritis.
    Van Hoovels L; Jacobs J; Vander Cruyssen B; Van den Bremt S; Verschueren P; Bossuyt X
    Ann Rheum Dis; 2018 May; 77(5):667-677. PubMed ID: 29363510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-citrullinated protein/peptide antibodies (ACPA) in rheumatoid arthritis: specificity and relation with rheumatoid factor.
    Vander Cruyssen B; Peene I; Cantaert T; Hoffman IE; De Rycke L; Veys EM; De Keyser F
    Autoimmun Rev; 2005 Sep; 4(7):468-74. PubMed ID: 16137613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between number and type of different ACPA fine specificities with lung abnormalities in early, untreated rheumatoid arthritis.
    Joshua V; Hensvold AH; Reynisdottir G; Hansson M; Cornillet M; Nogueira L; Serre G; Nyren S; Karimi R; Eklund A; Sköld M; Grunewald J; Chatzidionysiou K; Catrina A
    RMD Open; 2020 Sep; 6(2):. PubMed ID: 32917833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination of anti-citrullinated protein antibodies and rheumatoid factor is associated with increased systemic inflammatory mediators and more rapid progression from preclinical to clinical rheumatoid arthritis.
    Lingampalli N; Sokolove J; Lahey LJ; Edison JD; Gilliland WR; Holers VM; Deane KD; Robinson WH
    Clin Immunol; 2018 Oct; 195():119-126. PubMed ID: 29842946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emergence of rheumatoid arthritis following exposure to natalizumab.
    Su E; Novic J; Han MH
    Mult Scler Relat Disord; 2020 May; 40():101936. PubMed ID: 31982664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rheumatoid meningitis: A systematic review and meta-analysis.
    Villa E; Sarquis T; de Grazia J; Núñez R; Alarcón P; Villegas R; Guevara C
    Eur J Neurol; 2021 Sep; 28(9):3201-3210. PubMed ID: 33966315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Poncet's disease with high titers of rheumatoid factor and anti-citrullinated peptide antibodies mimicking rheumatoid arthritis.
    Sasaki H; Inagaki M; Shioda M; Nagasaka K
    J Infect Chemother; 2015 Jan; 21(1):65-9. PubMed ID: 25150438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.